Heart Failure Research Review: Issue 80, with commentary by Dr Mark Nolan

In this edition:

–  Ferric carboxymaltose in HF with iron deficiency
–  Semaglutide in HFPEF and obesity
–  Clinical characteristics and HF outcomes: LVEF thresholds and inflection points
–  Obesity in HFPEF with or without diabetes
–  VAI and HF risk, late-life cardiac structure and function
–  Blinded withdrawal of long-term empagliflozin or placebo in HF
–  Cardiac and metabolic effects of dapagliflozin in HFPEF
–  Age, sex and outcomes in HFREF
–  5-year mortality in patients managed with magnetically levitated LVAD
–  MRA underutilisation in HFREF

Download  Heart_Failure_Research_Review_Issue_80 (pdf)

R T Hall Prize

We are delighted to announce the 2023 R T Hall Prize is awarded to Prof Gemma Figtree AM. The RT Hall Prize is the most prestigious research award of CSANZ and recognises the achievements of senior and established investigators.

Over the last 10 years Prof Figtree has led an expanding international team addressing the mechanisms and unmet needs regarding clinical pathways for patients who develop coronary artery disease and myocardial infarction despite no standard modifiable risk factors (SMuRFs).

She is the National Scientific Lead of the large global clinical trial AEGIS II and was appointed to the adjudication panel, co-leading the heart failure analyses and publications for the highly cited CANVAS program demonstrating of benefits of SGLT2 inhibition in diabetics.

Using validated pre-clinical models, she has made seminal contributions that have provided unique insights into the mechanisms of cardiovascular disease susceptibility.

An impressive line up!

Captured at this year’s CSANZ ASM was an impressive line up of previous R T Hall Prize winners. Pictured together here, at the 2023 CSANZ ASM President’s Welcome on Thursday evening – an “RT Hall Prize Hall of Fame”. 

View the full list R T Hall Prize winners below from 1965 to date. 

(from left to right): Prof Paul Nestel (awarded in 1965, the first RT Hall Prize recipient), guest with Prof Gerald Watts (2022), Prof Phil Aylward (1984) and Prof Stephen Nicholls (2018). 

 

LIVE PANEL | Managing CVD with Obesity | Outcomes from the AHA Scientific Sessions 2023

ADS will host an exciting virtual event.
Join the experts, including Prof John Atherton, A/Prof Sarah Glastras, A/Prof Samantha Hocking, Prof Stephen Nicholls and Prof Sophia Zoungas for a Live Panel Discussion on Monday 13 November 2023 from 7.00pm – 8.00pm (AEDT). 

Discussion will cover the outcomes of the 2023 AHA Scientific Sessions in relation to managing cardiovascular disease in people living with obesity, plus a review of the trial results presented at the AHA Meeting.   Download the flyer for full details.  Register here for the Live Discussion 

LIVE PANEL | Managing CVD with Obesity | Outcomes from the AHA Scientific Sessions 2023

ADS will host an exciting virtual event. Join the experts, including Prof John Atherton, A/Prof Sarah Glastras, A/Prof Samantha Hocking, Prof Stephen Nicholls and Prof Sophia Zoungas for a Live Panel Discussion on Monday 13 November 2023 from 7.00pm – 8.00pm (AEDT). 

Discussion will cover the outcomes of the 2023 AHA Scientific Sessions in relation to managing cardiovascular disease in people living with obesity, plus a review of the trial results presented at the AHA Meeting.   Download the flyer for full details here 

Heart, Lung and Circulation October Highlights

Highlights and more are available online now and in the upcoming October 2023 edition of Heart, Lung and Circulation

Does Australia need Cardiogenic Shock Teams?

Cardiogenic shock is the most common cause of death following acute myocardial infarction, with in-hospital mortality rates of 40%. In their narrative review, Kruit and colleagues discuss the rationales, evidence for and a proposed structure for an in-hospital cardiogenic shock or “heart” team that manages cardiogenic shock via an agreed protocol, including agreed referral pathways. They say the Medical Research Future Fund (MRFF-funded Evaluation of a Standardised ClinicAl Pathway to improve Equity and outcomes in Cardiogenic Shock (ESCAPE-CS) trial may assist in the process of answering many of the questions around management, transfer timings and cost of care.
https://www.heartlungcirc.org/article/S1443-9506(23)04325-1/fulltext

What’s happening with Long-COVID Care?
Australia is likely to have a case burden of upwards of 300,000 people with long-COVID, say Seeley et al. In a Letter to the Editor, they report their cross-sectional online survey of participants (227; about 90% female) with long-COVID. Recruited via social media earlier this year (2023), many had experienced autonomic dysfunction, with about half eventually diagnosed with postural orthostatic tachycardia syndrome (POTS). However, getting a diagnosis and accessing care was difficult. Further, half had not been able to return to work or education since developing long-COVID. Seeley et al. support calls for innovative health care solutions for people with long-COVID, with special attention to the diagnosis and management of autonomic dysfunction.
https://www.heartlungcirc.org/article/S1443-9506(23)04311-1/fulltext

Who Wants a Career in Cardiology?
Commonly identified, perceived barriers to wanting to pursue cardiology as a career include (in order): poor work–life balance; the physician training and examination process; and the lack of flexibility and on–call requirements — with no difference between men and women. These were among the key findings of Perera et al.’s anonymous, online survey in May 2019, which analysed responses from 127 medical students from three universities in Victoria. They say that if the cardiology profession wishes to attract the best candidates, it must acknowledge that today’s medical students value work–life balance as a critical factor in deciding on a career.
https://www.heartlungcirc.org/article/S1443-9506(23)00524-3/fulltext

Compiled by Dr Ann Gregory, Commissioning Editor, Heart, Lung and Circulatio([email protected]).

Cardiology Practice Review: Issue 31, with commentary by Dr Janette Tenne

In this issue:

–  2023 ESC cardiomyopathy guidelines
–  Exercise and physical activity in cardiac rehabilitation
–  Focused update of ESC heart failure guidelines
–  2023 ESC guidelines for patients with CVD and diabetes
–  Screening for hypertensive disorders of pregnancy
–  CVD in women
–  60-day prescriptions of PBS medicines
–  Statin intolerance: An overview of US and international guidance
–  Cuff size affects the accuracy of BP readings
–  Shared decision-making in international CV guidelines
–  Temperature management for comatose adult survivors of cardiac arrest
–  COVID-19 resources
–  Conferences, workshops and CPD

Download Cardiology_Practice_Review_Issue_31 here (pdf) 

*NEW* Heart Failure Practice Review Issue 1, with commentary by Prof Andrew Coats

A new Practice Review for Heart Failure, with commentary by Prof Andrew Coats.  

Look forward to updates and new treatment guidelines, changes to medicines reimbursement and licensing, educational and professional body news plus plus  our COVID-19 resources for Cardiologists. This issue:

–  Focused update of ESC HF guidelines
–  CPP for avoiding and mitigating HF
–  Managing HFpEF
–  Safety and efficacy of empagliflozin in patients with HFpEF using diuretics
–  Comparison of current HF international guidelines
–  Cardio-obstetrics and HF
–  60-day prescriptions of PBS medicines
–  Semaglutide improves HF and CVD
–  Complete revascularisation impact on HF in patients with ACS and MVD
–  Sex-based differences in acute HF treatment and outcomes
–  COVID-19 resources
–  Conferences, workshops and CPD

Download the Heart Failure Practice_Review_Issue_1

CSANZ Members – Sports Cardiology Working Group

Welcome to the CSANZ Sports Cardiology Working Group

In 2021 CSANZ formed a working group for Sports Cardiology due to the increased demand for training and a dedicated service provision for this niche field, whilst also providing a forum for discussing interesting cases and progress within Sports Cardiology.  

Read more about the emerging subspecialty Sports Cardiology here

BENEFITS OF BEING PART OF THE CARDIOLOGY WORKING GROUP:
  • Invitation to the Sports Cardiology Working Group Meeting at the CSANZ ASM.
  • Access to collaborative research opportunities.
  • Access to educational and networking events.
  • Be part of the grass roots of a new subsection of cardiology in Australasia.
CSANZ ASM 2023
HOW TO JOIN THE WORKING GROUP

 (current CSANZ membership is essential)

As we build our profile of experts, we invite you to contact us on [email protected] if you have an interest in research opportunities, collaborations, education or training in the field, attending events and  building a valuable resource for those working in sports cardiology.

It’s very easy to join the Sports Cardiology Working Group, contact us by email with your name and contact details and subject: Join the Sports Cardiology Working Group and send it to [email protected].

UPCOMING EVENTS
1 – 3 March 2024
International Sudden Cardiac Arrest and Sports Symposium, Lorne, VIC

Details to follow soon.

8 -10 May 2024
International Clinical Cardiovascular Genetics Conference 2024, Brisbane, QLD (ICCG 2024)

Calling for Abstracts           Read more

The closing date for abstract submission is 28 February 2024.

SPECIALISED CLINICS

We have developed dedicated specialised sports cardiology services in Melbourne (St Vincent’s Hospital) and Sydney (RPAH) and are aware of several specialists around Australia and New Zealand who have a dedicated interest and expertise. If you wish to refer a patient to our dedicated subspecialized sports cardiology clinics the contact details are below:

SPORTS CARDIOLOGY FOCUS OF THE MONTH
We would love to see you sharing an ECG, image or interesting case in this section, please email your images to: [email protected] with Sports Cardiology Focus of the Month in the subject line.
LATEST JOURNAL ARTICLES

Clinical outcomes of 10 years of cardiac screening in elite New Zealand athletes
Journal of Science and Medicine in Sport 

Author:  Jessica J. Orchard et al
 
CURRENT GUIDELINES OF SPORTS CARDIOLOGY
PERFORMANCE MEASURES AND OTHERS
POSITION STATEMENTS AND CONSENSUS DOCUMENTS
OTHER PUBLICATIONS

Link to other Articles in European Heart Journal (EHJ)                Link to other articles in the JACC Journal  

OTHER RESOURCES

Links to International Sports Cardiology website resources:

Posts navigation